Cell line · CVCL_0399

LoVo

Cancer cell line, Homo sapiens. Colon adenocarcinoma. 153 papers.

4 sourcescell-lines-2026-11-14-0.1.0

Cite this record

ConductScience Library. LoVo. Cell lines, record CVCL_0399. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0399

On this page

Cell line

As Cellosaurus gives it.

Name: LoVo
Accession: CVCL_0399
RRID: RRID:CVCL_0399
Synonyms: LOVO
Species: Homo sapiens (Human)
Sex: Male
Age at sampling: 56Y
Category: Cancer cell line
Diseases: Colon adenocarcinoma (NCIt C4349)
Derived from: Left supraclavicular lymph node (metastatic)
Entry created: 2012-04-04
Entry updated: 2026-06-25

Source Cellosaurus

Problems0

Cellosaurus records no problem for this cell line.

None in this release.

Papers153

Paper	Journal	Year	How we know	Source
NDFIP2 Suppresses Colorectal Cancer Metastasis Through DDX3X-Dependent R-Loop Remodeling and GNG13 Transcriptional Activation.	Adv Sci (Weinh)	2026	Its Methods give the RRID and name the line	PubMed
MZF1 Inhibits TGFβ-1/SMAD Signaling by Transcriptionally Activating SnoN to Augment Tumorigenic Potential in Colon Cancer.	Adv Sci (Weinh)	2026	Its Methods give the RRID and name the line	PubMed
The Mechanism Underlying Inhibition of Colorectal Cancer Invasion by Quxie Capsule Through CRK-RAC Signaling Pathway Regulation.	Integr Cancer Ther	2026	Its Methods give the RRID and name the line	PubMed
Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer.	Cancer Res	2026	Its Methods give the RRID and name the line	PubMed
CLK3 regulates tumor angiogenesis by modulating HIF1α ubiquitination.	Cancer Gene Ther	2026	Its Methods give the RRID and name the line	PubMed
Overcoming Daraxonrasib Resistance: Allele-Specific Mechanisms Guide Salvage Therapy in Pancreatic Cancer.	bioRxiv	2026	Its Methods give the RRID and name the line	PubMed
HP1γ promotes the progression of colorectal cancer through interaction with RBPJ of the Notch signaling pathway.	Cell Biol Toxicol	2026	Its Methods give the RRID and name the line	PubMed
FUT2-Mediated Fucosylation of OLFM4 Promotes Colon Cancer Cell Differentiation.	Can J Gastroenterol Hepatol	2026	Its Methods give the RRID and name the line	PubMed
PRKN mediates the ubiquitination of SCAF8 to reduce the mRNA stability of KLF5 and its transcriptional activation of EFNA3 in colorectal cancer.	Cell Mol Biol Lett	2026	Its Methods give the RRID and name the line	PubMed
Soluble Uric Acid Drives CD8+ T-cell Exhaustion by Inducing KSR1-Mediated MAPK Hyperactivation.	Cancer Res	2026	Its Methods give the RRID and name the line	PubMed

1 to 10 of 153

See all 153 papers

Relatives15

Relation	Cell line	Accession	Source
Derived from it	EDITGENE LoVo-FLUC	CVCL_F6D9	Cell lines
Derived from it	HyCyte LoVo KO-hIDO1	CVCL_F4DT	Cell lines
Derived from it	HyCyte LoVo-Luc	CVCL_E3HU	Cell lines
Derived from it	LoVo-6-luc-1	CVCL_5J42	Cell lines
Derived from it	LoVo-92	CVCL_5237	Cell lines
Derived from it	LoVo-Luc#2	CVCL_4Y03	Cell lines
Derived from it	LoVo-MEK-R	CVCL_V402	Cell lines
Derived from it	LoVo/Cas9-hyg	CVCL_C9ES	Cell lines
Derived from it	LoVo/DR5	CVCL_6C49	Cell lines
Derived from it	LoVo/L-OHP	CVCL_4V75	Cell lines

1 to 10 of 15

See all 15 relatives

Cell banks19

Cell bank	Catalog number	Source
ATCC	CCL-229	ATCC
AddexBio	C0009011/380	Cellosaurus
BCRC	60148	BCRC
BCRJ	0332	BCRJ
CCLV	CCLV-RIE 1151	Cellosaurus
CCTCC	GDC0186	Cellosaurus
CLS	300266	CLS
DSMZ	ACC-350	DSMZ
ECACC	87060101	ECACC
ICLC	HTL99028	ICLC

1 to 10 of 19

See all 19 cell banks

Data dates

The date of each source this release read.

Cellosaurus: 2026-10-22; Cellosaurus
PubMed Central's articles: 2026-11-12; PubMed Central's articles
Our copy of PubMed: 2026-11-06; Our copy of PubMed

Sources 4

CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
PubMedNLM's terms

Each source's terms

CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this cell line from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_0399

GET https://conductscience.org/api/cell-lines/v1/CVCL_0399/papers?page=2

API reference For AI assistants